@article{dcab6711f2e04264906b10cdbfaed480,
title = "Galectin-3 promotes vascular remodeling and contributes to pulmonary hypertension",
author = "Barman, {Scott A.} and Feng Chen and Xueyi Li and Stephen Haigh and Stepp, {David W.} and Dmitry Kondrikov and Keyvan Mahboubi and Zsuzsanna Bordan and Peter Traber and Yunchao Su and Fulton, {David J.R.}",
note = "Funding Information: This work was supported by NIH grants R01HL125926-01A1 (D.J.R.F. and S.A.B.) and 1R01HL124773-01A1 (D.W.S. and D.J.R.F.) and Augusta University PSRP Award 00073 (S.A.B. and D.J.R.F.). The galectin-3 inhibitors were supplied by Galectin Therapeutics, Inc., Norcross, Georgia.",
year = "2018",
month = jun,
day = "1",
doi = "10.1164/rccm.201711-2308LE",
language = "English (US)",
volume = "197",
pages = "1488--1492",
journal = "American Review of Respiratory Disease",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "11",
}